arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Onconetix, Inc.

ONCO

$0.91 ▼ -0.05 (-5.47%) at close

6 Visible periods

26 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Onconetix, Inc. shows weak fundamentals, weighed down by Interest Coverage and FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap —

Dividend Yield —

Revenue Growth -67.7% ↘

Op. Margin —

ROIC None

FCF / Share $-10.32

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 6, 2026.

6-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$815.37K

↓ -67.7% —

Net Income Profit after all expenses

$-14.03M

↑ +76.1% —

FCF / Share Free cash flow per share

$-10.32

↓ -1200.1% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Interest CoverageInterest Coverage of -23.30x is weak on an absolute basis (target > 5x)
FCF / Net IncomeFCF / Net Income of 0.69x is weak on an absolute basis (target > 1x)

Health Breakdown

Financial Health ↑

Cash Quality ↑

Dividend History

Dividend / share · sourced from SEC filings

$1.23 Latest / share

FY 2020

FY 2021

$1.23

FY 2022

FY 2023

FY 2024

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue Growth YoY (%)	-67.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-946%)	4217.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+52616%)	—	—	—	—
EPS Growth YoY (%)	99.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-83159.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-99.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	12.7% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	76.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-56.9% Weak ↑ Weak Improving Year-over-year change in net income	-178.8% Weak Weak Year-over-year change in net income	-292.7% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	—	—	-11.9% Weak Weak Year-over-year change in free cash flow	-11.0% Weak Weak Year-over-year change in free cash flow	—	—

💰 Are margins durable? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Effective Tax Rate (%) (%)	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.7% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—
FCF Margin (%) (%)	—	-416.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—
FCF / Net Income (x)	0.69x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.18x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.36x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	—	—	643.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-47.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-186.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-71.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-200.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-41.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-51.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-110.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	—	—	—	-59.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-500%)	-236.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1675%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Interest Coverage (x)	-23.30x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-148.89x Weak Weak Operating income divided by interest expense Optimal: > 5x	-53.65x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	—	—	—	$-25.75M	$-1.93M	—

📊 What does each share earn? 8 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue per Share (USD)	$0.87	—	$0.00	—	—	—
Basic EPS, GAAP (USD)	$-16.56	$-1.82K	$-2.19	$-1.10	$-1.26	—
Free Cash Flow per Share (USD)	$-10.32	—	$-0.79	$-0.71	$-0.64	—
Dividend per Share (USD)	—	—	—	$1.23	—	—
Book Value per Share (USD)	—	—	$-0.25	$1.47	$0.45	—
Tangible Book Value per Share (USD)	—	—	$-3.88	$1.47	$0.45	—
Basic Weighted Avg Shares (shares)	937,690	32,301	17.11M	12.27M	3.20M	—
Dividend Payout Ratio (%)	—	—	—	-111.8% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$-3.07M	$-17.34M	$-11.35M	$22.34M	$1.44M	—
Total Equity (USD)	—	—	$-5.60M	$22.39M	$1.45M	$4.73M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	$815.37K	$2.52M	$58.47K	—	—	—
Depreciation Expense (USD)	$15.00K	$22.00K	$43.94K	$6.75K	$4.89K	—
Net Income, GAAP (USD)	$-14.03M	$-58.69M	$-37.41M	$-13.42M	$-3.42M	—
Operating Cash Flow (USD)	$-9.68M	$-10.50M	$-13.58M	$-8.70M	$-2.04M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 22 quarters

Onconetix, Inc.

Analytical Summary

6-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare ONCO with peers